Guo, W., Patel, M. R., Gabrail, N., Rodon, J., Hamilton, E., Yap, T. A., . . . Dezube, B. J. IOLite: Phase 1b trial of doublet/triplet combinations of dostarlimab with niraparib, carboplatin–paclitaxel, with or without bevacizumab in patients with advanced cancer. BMJ Publishing Group.
Chicago Style (17th ed.) CitationGuo, Wei, et al. IOLite: Phase 1b Trial of Doublet/triplet Combinations of Dostarlimab with Niraparib, Carboplatin–paclitaxel, with or Without Bevacizumab in Patients with Advanced Cancer. BMJ Publishing Group.
MLA (9th ed.) CitationGuo, Wei, et al. IOLite: Phase 1b Trial of Doublet/triplet Combinations of Dostarlimab with Niraparib, Carboplatin–paclitaxel, with or Without Bevacizumab in Patients with Advanced Cancer. BMJ Publishing Group.
Warning: These citations may not always be 100% accurate.